BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25100611)

  • 1. Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.
    Pfeiffer IA; Hoyer S; Gerer KF; Voll RE; Knippertz I; Gückel E; Schuler G; Schaft N; Dörrie J
    Eur J Immunol; 2014 Nov; 44(11):3413-28. PubMed ID: 25100611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
    Hansen M; Hjortø GM; Donia M; Met Ö; Larsen NB; Andersen MH; thor Straten P; Svane IM
    Vaccine; 2013 Jan; 31(4):639-46. PubMed ID: 23200882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic T lymphocytes having increased homing signals to cancer.
    Hong CY; Kim SY; Lee HJ; Lee SE; Lim SC; Rhee JH; Lee JJ
    J Immunother; 2014 Jan; 37(1):16-25. PubMed ID: 24316552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.
    Ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; van Ham SM
    Vaccine; 2007 Oct; 25(41):7145-52. PubMed ID: 17719152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third generation dendritic cell vaccines for tumor immunotherapy.
    Frankenberger B; Schendel DJ
    Eur J Cell Biol; 2012 Jan; 91(1):53-8. PubMed ID: 21439674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
    Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
    J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway.
    Ding J; Feng T; Ning Y; Li W; Wu Q; Qian K; Wang Y; Qi C
    Hum Immunol; 2015 Mar; 76(2-3):146-54. PubMed ID: 25636576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
    Jung MY; Son MH; Kim SH; Cho D; Kim TS
    J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl-Transfer RNA Synthetase Induces the Maturation of Dendritic Cells through MAPK and NF-κB Pathways, Strongly Contributing to Enhanced Th1 Cell Responses.
    Lim HX; Jung HJ; Lee A; Park SH; Han BW; Cho D; Kim TS
    J Immunol; 2018 Nov; 201(9):2832-2841. PubMed ID: 30275047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
    Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
    J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.